Transaction · 0001178913-26-004371

Cohen Neil Harris

Cohen Neil Harris, DIR, reported an open-market or private sale at Chemomab Therapeutics Ltd. involving 1000.000000 shares for an estimated $2800.00. Reported holdings after the transaction were 33000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
CMMBChemomab Therapeutics Ltd.
Trade date
Aug 28, 2026
Filing date
Sep 01, 2026
View on SEC Insider profile
Estimated value-$2.80kShares × reported price
Shares traded1.00k$2.80 per share
Holdings after33.0kDirect
% of reported position traded2.94%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 34,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CMMB price since this filing

Daily closing prices, with the filing date and available return windows
CMMB · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +0.7%30d -56.4%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001178913-26-004371
American Depositary Shares
Transaction date
Aug 28, 2026
Filed Sep 01, 2026, 02:05 PM · 4d delay
Shares
1,000 sh
$2.80 per share
Estimated value
-$2.80k
Computed from shares × price
Holdings after
33,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report.

  2. F2

    The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report.

  3. F3

    The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report.

  4. F4

    The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report.

  5. F5

    The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report.

  6. F6

    The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report.

Original filing · 0001178913-26-004371
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CMMB